Date published: 2026-5-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

Shc Inhibitors

Shc inhibitors belong to a distinct chemical class of compounds that hold significance due to their intricate role in cellular signaling pathways. These inhibitors target the Shc proteins, which are crucial intermediaries in various signal transduction cascades. Shc proteins, comprising several isoforms, function as adapters in signal transmission from activated cell surface receptors to downstream signaling components within the cell. Their role is pivotal in mediating responses to extracellular stimuli, such as growth factors and cytokines, by conveying signals that govern cell proliferation, differentiation, migration, and survival.

The mechanism of action of Shc inhibitors lies in their ability to impede the interaction between Shc proteins and upstream signaling partners. By targeting specific domains within Shc proteins that facilitate these interactions, the inhibitors disrupt the transmission of signals along their intended pathways. This interference can have profound effects on cellular behavior, as the perturbation of Shc-dependent signaling cascades may alter the fate of the cell and its responses to external cues. The development of Shc inhibitors represents a significant advancement in our understanding of intracellular communication networks and provides researchers with a valuable tool for investigating the intricate regulatory mechanisms governing cellular processes. Further research into the precise mechanisms by which Shc inhibitors modulate signaling events will undoubtedly contribute to the broader knowledge of cellular biology and may have implications in diverse areas of biological research and applications.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Blocks MEK1/2 phosphorylation, interfering with MAPK/ERK signaling and influencing cell proliferation and differentiation.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Targets RAF kinases and receptors, disrupting pathways related to angiogenesis and cell proliferation.

Selumetinib

606143-52-6sc-364613
sc-364613A
sc-364613B
sc-364613C
sc-364613D
5 mg
10 mg
100 mg
500 mg
1 g
$29.00
$82.00
$420.00
$1897.00
$3021.00
5
(1)

Inhibits MEK1/2, disrupting the MAPK pathway and potentially slowing cancer growth by affecting cell proliferation.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

Specifically inhibits MEK1/2, disrupting the MAPK pathway and potentially inhibiting cancer cell proliferation.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Dual EGFR/HER2 inhibitor, disrupting downstream signaling pathways involved in cell growth and survival.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Targets SFKs, BCR-ABL, and other kinases, affecting pathways crucial for cell growth, proliferation, and survival.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Inhibits BCR-ABL and c-KIT tyrosine kinases, interfering with signaling pathways involved in cell proliferation.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

Targets BCR-ABL, inhibiting its activity and downstream signaling.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

EGFR tyrosine kinase inhibitor, blocking signaling pathways driving uncontrolled cell growth in specific cancers.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Selectively inhibits EGFR, disrupting downstream pathways associated with cell proliferation and survival.